GET A PIECE OF REVOLUTION MD
Reinventing Medication Delivery
$58,210.47 Raised
REASONS TO INVEST
Opportunity to Invest in a Growing Biotech Market | The global biotechnology market stood at USD $627.63 Billion in 2020 and is expected to grow at a CAGR of 8.57% through 2026, while the global market for opioids was estimated at USD $25.4 Billion in 2020 and projected to reach US$31.9 Billion by 2027***
Revolution MD is supported by a world-class team of experts in pharmaceutical, regulatory, healthcare, cyber security, and finance industries, including Igor Gonda Pharma CEO, who successfully developed an opioid inhaler and navigated clinical trials.
Technology is Proven: 11 clinical trials have demonstrated the efficacy of inhaled opioids with fewer side effects
The Solution
*Images above are computer-generated renderings of the INHALE device. Product is currently under development.
Our Business Model
*Images above are computer-generated renderings of the INHALE device. Product is currently under development.
*Images above are computer-generated renderings of the INHALE device. Product is currently under development.
Why Invest
*Images above are computer-generated renderings of the INHALE device. Product is currently under development.
(or click)
ABOUT
HEADQUARTERS
5600 Crooked Pine Lane
Knoxville, TN 37921
WEBSITE
View Site
Revolution MD has developed a solution to the opioid epidemic. Our patented Smart Inhaler combines biometric authentication with abuse deterrents in a proprietary blockchain network, for a real solution to prevent overdose and properly taper off medication as prescribed by physicians. Designed alongside healthcare providers and supported by a team of pharmaceutical and regulatory experts, we believe our portable device will make the opioid crisis a thing of the past, finally providing a solution to a problem that affects millions of Americans.
TEAM
Josh Kimmel
President & Founder
Ken Greenwood
Chief Technology Officer
Mike Agentis
Chief Operating Officer
Jurgen Volrath
Chief Intellectual Property Officer
Garo Artinian
Advisory to Operations
Igor Gonda
Chief Scientist
Don Treacy
Clinical Development Manager
Susan Clausen
Clinical Trials Manager
Richard Dapaah
Venture Advisor
Paresh Chari
Advisor
Bill Pittman
Advisor
TERMS
Revolution MD
Overview
PRICE PER SHARE
$2
DEADLINE
Jul 29, 2022
VALUATION
$26.71M
FUNDING GOAL
$10k - $1.07M
Breakdown
MIN INVESTMENT
$250
MAX INVESTMENT
$107,000
MIN NUMBER OF SHARES OFFERED
5,000
MAX NUMBER OF SHARES OFFERED
535,000
OFFERING TYPE
Equity
ASSET TYPE
Common Stock
SHARES OFFERED
Common Stock
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
Investment Incentives and Bonuses
Time-Based
Friends and Family Early Birds
Invest within the first 72 hours and receive 20% Bonus Shares.
Super Early Bird Bonus
Invest within the first week and receive 15% Bonus Shares.
Early Bird Bonus
Invest within the two weeks and receive 10% Bonus Shares.
Amount-Based
$1,000+ | Tier 1
Invest $1,000+ and receive 5% Bonus Shares.
$2,000+ | Tier 2
Invest $2,000+ and receive 10% Bonus Shares.
$5,000+ | Tier 3
Invest $5,000+ and receive 15% Bonus Shares.
$10,000+ | Tier 4
Invest $10,000+ and receive 20% Bonus Shares.
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Revolution MD will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.00 / share, you will receive 110 Common Stock, meaning you'll own 110 shares for $200. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Any expense labeled “Travel and Entertainment”. Salary payments made to one’s self, a friend or relative.
ALL UPDATES
REWARDS
JOIN THE DISCUSSION
0/2500
Nikki Puiia
a year ago
Also, could you explain WHY and HOW prescription opioids are fueling the epidemic? I saw your source from 2015 about prescription abuse. What about the report released by the DEA in 2021 that says the diversion and abuse of opioid painkillers and other controlled prescription drugs (CPDs) are at their “lowest levels in nine years.”? Less than 1% of these pills are diverted. If it’s the lowest level in 9 years, how exactly is it fueling the current epidemic? Could you explain what exactly your product will fix? It sounds like you’re trying to fix a problem we had in 2015, not our current problem. If I could get an explanation on which problem we are facing in 2022 that you intend to fix, that would be really helpful. Here is the report I’m referring to. Thanks in advance! https://static1.squarespace.com/static/54d50ceee4b05797b34869cf/t/6056561b94da796fd4174ef0/1616270887543/DIR-008-21+2020+National+Drug+Threat+Assessment_WEB.pdf
2
0
Nikki Puiia
a year ago
Do you have any sources from 2021-2022 or did you stop looking when they started disputing your “facts”? Could you tell us how many overdoses a day or even a year are caused by prescription pills ONLY. Not poly pharmacy? The vast majority of overdoses are caused by illegal street drugs. How does this product prevent that? Exactly how many overdoses would this product prevent when you don’t include street drugs in the equation? Our epidemic is a fentanyl and heroin epidemic. How will this product make even a small dent in this epidemic?
0
0
Adam Beiter
2 years ago
Can you please answer my two previous questions. Not a good start for showing you're not like the rest of them.
1
0
Adam Beiter
2 years ago
Will there be a Buprenorphine-naloxone one as well, Methadone has almost as bad a reputation as opiates?
3
0
Adam Beiter
2 years ago
Smoking opiates is the second fastest way to get the drug in the system The faster the drug gets in your system the more euphoria, how will this reduce addiction?
2
0
Michael Nadler
2 years ago
So this is essentially a blockchain based/smart contract ish pill bottle that dispenses the correct prescribed dose in the form of inhaling the "pill"? How about when you're on 2 pain medications at once- do you need to have 2 rev mds? Walk me through the logistics of this a little further- i.e. the doctor prescribes said opoid medication and then the patients goes to the pharmacy and picks up their pill bottle which is rev md and then rev md is using blockchain/smart technology to give the prescription to the patient accordingly? Lastly, what blockchain technology are you using- is it Ethereum or something else?
1
0
Kirtson Thompson
2 years ago
A clear market need to bring greeter safety to the opioid dispensing market. A few questions:
1. Do you envision that every opioid prescription is fulfilled with your inhaler?
2. If so, what is your marketing strategy to fast track adoption (opioid manufacturer and pharmacy partnerships, etc)?
3. How long before you expect to have your FDA submission for review/approval?
4. What is your moat or barrier to entry by existing well funded big pharma?
5. What prevents a patient from bypassing the security of the inhaler to access the product?
3
0
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Kenneth Munson
a year ago
0
0